ST-SB1 (D)

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2018-08-08 for ST-SB1 (D) manufactured by Olympus Medical Systems Corp..

Event Text Entries

[116372827] Olympus representative visited the user facility to obtain additional information including the outcome of the patient. However, the user facility refused to provide the information. The subject device was not been returned to omsc. The exact cause of the reported event could not be conclusively determined at this time. If additional information is received, this report will be supplemented. The operation manual has already warned; - if resistance is felt, do not continue insertion or withdrawal any further. Doing so may cause patient injury, bleeding, perforation, and/or equipment damage.
Patient Sequence No: 1, Text Type: N, H10


[116372828] Olympus medical systems corp. (omsc) was informed that during an ercp (endoscopic retrograde cholangiography) procedure using the subject device, which intended to perform a metallic stent placement for stricture in the hepatic portal region of the patient, the intestinal tract of the patient was perforated. The patient had experienced a roux-en-y anastomosis procedure following gastric resection before the ercp procedure. In the early stages of the procedure, the user facility used the sif-h290s and an olympus splinting tube (the subject st-sb1s); however, the sif-h290s could not pass through the anastomotic region, being unable to reach the papilla. Therefore, the user facility replaced them with another olympus small intestinal scope (sif-q260) and an olympus single use splinting tube (st-sb1), and inserted the sif-q260 and the st-sb1 up to the papilla. After that, the user facility removed the sif-q260 from the patient and cut a part at 15 cm from the proximal side of the st-sb1 with scissors, and then tried to insert the sif-h290s into the st-sb1. However, since the distal end of the st-sb1 was kinked at the intestinal anastomotic region, the sif-h290s could not be inserted. After forcibly straighten the kink, the user facility inserted the sif-h290s into the st-sb1 again. When the sif-h290s was inserted through the st-sb1 into the patient, the user facility noticed by unusual endoscopic image that the distal end of the sif-h290s perforated the intestinal wall and came into the abdominal cavity. The user facility then aspirated intestinal fluids leaking into the abdominal cavity as much as possible using the sif-h290s and performed an emergency ct scan for the patient. The intended procedure was aborted. The user facility commented that the patient? S perforation likely occurred since they pushed the kinked part of the st-sb1 too strong with the sif-h 290 s. Therefore, omsc submit the mdr regard with the sif-h290s and the st-sb1. This is a report on the st-sb1 (2 of 2 reports).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010047-2018-01565
MDR Report Key7760800
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2018-08-08
Date of Report2018-08-08
Date of Event2018-07-12
Date Mfgr Received2018-07-12
Date Added to Maude2018-08-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR KAZUTAKA MATSUMOTO
Manufacturer Street2951 ISHIKAWA-CHO
Manufacturer CityHACHIOJI-SHI, TOKYO-TO 192-8507
Manufacturer CountryJA
Manufacturer Postal192-8507
Manufacturer Phone426425177
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameST-SB1 (D)
Generic NameSINGLE USE SPLINTING TUBE
Product CodeFED
Date Received2018-08-08
Model NumberST-SB1
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOLYMPUS MEDICAL SYSTEMS CORP.
Manufacturer Address2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-08-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.